Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets 2024-11-18 21:50
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit 2024-11-18 21:16
VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate 2024-11-18 21:01
WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday 2024-11-18 21:00
TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection 2024-11-18 19:00
FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection 2024-11-18 18:40
Perennial Alzheimer's Care Village Xi'an Positioned as China's First and the World's Sixth Alzheimer's Care Village 2024-11-18 18:31
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence 2024-11-18 16:00
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions 2024-11-18 09:00
Boehringer Ingelheim Commits to Veeva Vault CRM 2024-11-18 09:00
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors 2024-11-18 09:00
Sky Labs' Wearable Device "Apollon" Recognized as an Honoree in CES 2025 Innovation Awards 2024-11-18 08:00
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors 2024-11-18 08:00
Getz Healthcare and IGEA Medical Announce Strategic Distribution Agreement to Introduce Adaptive Electroporation Technologies in Australia 2024-11-18 07:30
Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by CDE of China NMPA 2024-11-17 22:24
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth 2024-11-15 22:00
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease 2024-11-15 20:00
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer 2024-11-15 09:55
International Cancer Organizations Present Collaborative Work During Oncology Event in China 2024-11-15 09:04
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity 2024-11-14 23:45
1 17 18 19 20 21 977